Decertification Appealed In Wellbutrin Pay-For-Delay Suit
A class of indirect purchasers in the pay-for-delay litigation against GlaxoSmithKline PLC and others over the antidepressant Wellbutrin XL appealed its decertification to the Third Circuit last week after a Pennsylvania...To view the full article, register now.
Already a subscriber? Click here to view full article